Parkman Healthcare Partners LLC Has $3.04 Million Holdings in SI-BONE, Inc. (NASDAQ:SIBN)

Parkman Healthcare Partners LLC increased its stake in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 16.9% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 216,600 shares of the company's stock after acquiring an additional 31,284 shares during the period. Parkman Healthcare Partners LLC owned approximately 0.52% of SI-BONE worth $3,037,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SIBN. Mainstream Capital Management LLC acquired a new position in SI-BONE during the 4th quarter worth approximately $53,000. R Squared Ltd acquired a new position in shares of SI-BONE in the 4th quarter valued at approximately $73,000. KLP Kapitalforvaltning AS acquired a new position in shares of SI-BONE in the 4th quarter valued at approximately $97,000. Proficio Capital Partners LLC acquired a new position in shares of SI-BONE in the 4th quarter valued at approximately $155,000. Finally, AlphaQuest LLC raised its position in shares of SI-BONE by 13,950.6% in the 4th quarter. AlphaQuest LLC now owns 11,662 shares of the company's stock valued at $164,000 after purchasing an additional 11,579 shares in the last quarter. 98.11% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on SIBN. Needham & Company LLC reaffirmed a "buy" rating and issued a $24.00 target price on shares of SI-BONE in a research report on Tuesday, May 6th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $25.00 target price on shares of SI-BONE in a research report on Tuesday, May 6th. Finally, Truist Financial upped their target price on SI-BONE from $20.00 to $22.00 and gave the company a "buy" rating in a research report on Tuesday, May 6th.

SI-BONE Stock Performance

SIBN traded down $0.11 during trading on Monday, reaching $19.69. 224,236 shares of the company were exchanged, compared to its average volume of 373,505. The stock has a market cap of $838.88 million, a P/E ratio of -21.40 and a beta of 0.82. The firm has a 50 day moving average of $14.83 and a 200 day moving average of $15.04. The company has a current ratio of 8.25, a quick ratio of 7.22 and a debt-to-equity ratio of 0.22. SI-BONE, Inc. has a 52 week low of $11.70 and a 52 week high of $20.07.

SI-BONE (NASDAQ:SIBN - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported ($0.15) EPS for the quarter, topping analysts' consensus estimates of ($0.24) by $0.09. SI-BONE had a negative return on equity of 22.51% and a negative net margin of 23.82%. The firm had revenue of $47.29 million during the quarter, compared to the consensus estimate of $45.13 million. On average, sell-side analysts forecast that SI-BONE, Inc. will post -0.78 EPS for the current fiscal year.

Insider Transactions at SI-BONE

In related news, CFO Anshul Maheshwari sold 4,937 shares of the firm's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $19.02, for a total transaction of $93,901.74. Following the completion of the transaction, the chief financial officer now owns 232,069 shares of the company's stock, valued at $4,413,952.38. This trade represents a 2.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Anthony J. Recupero sold 3,311 shares of the company's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $14.15, for a total value of $46,850.65. Following the sale, the insider now directly owns 284,555 shares of the company's stock, valued at approximately $4,026,453.25. This represents a 1.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 55,153 shares of company stock valued at $935,040. 4.00% of the stock is currently owned by corporate insiders.

SI-BONE Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.